Article

Silicone hydrogel lens backed by guarantee

Atlanta-CIBA Vision has extended its Platinum Guarantee to include its recently introduced O2OPTIX silicone hydrogel lens.

Atlanta-CIBA Vision has extended its Platinum Guarantee to include its recently introduced O2OPTIX silicone hydrogel lens.

Introduced in September 2004, O2OPTIX is a 2-week replacement lens addition to CIBA Vision's line of silicone hydrogel lenses. O2OPTIX provides the highest oxygen transmissibility of any 2-week soft lens and is designed for patients who follow a daily wear regimen with occasional overnight wear, according to the company. O2OPTIX has FDA approval for daily wear and up to 6-night extended wear.

In March 2004, CIBA Vision originally announced the Platinum Guarantee to aid practitioners when refitting Night & Day lenses for patients who currently wear soft lenses. Night & Day has FDA approval for up to 30 nights continuous wear and is ideal for patients who regularly sleep in their contact lenses. The guarantee offers refunds on up to four boxes returned by patients, as well as a $40 credit to help offset the time spent refitting. The new "Double Platinum" guarantee now includes O2OPTIX, with the same terms as the original program. The "Double Platinum" guarantee will remain in effect until the end of 2005.

"Our 'Double Platinum' guarantee provides reassurance to eyecare professionals who have been hesitant to begin upgrading to the new generation of advanced soft lens materials for their patients."

Details of the "Double Platinum" guarantee are available from CIBA Vision customer service and sales representatives.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.